Collegium Pharma (COLL)

STOUGHTON, Mass., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD product,...

3 Small-Cap Stocks We’re Skeptical Of

– Product Revenues, Net Expected in the Range of $805 Million to $825 Million – – Jornay PM ® Net Revenue Expected in the Range of $190 Million to $200 Million – – Adjusted EBITDA*...

3 Russell 2000 Stocks Walking a Fine Line

STOUGHTON, Mass., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), today announced the closing of its inaugural syndicated credit facility. The new aggregate $980 million...

2 Reasons to Avoid COLL and 1 Stock to Buy Instead

3 Cash-Producing Stocks We Think Twice About

3 Unpopular Stocks We Find Risky

Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

1 Growth Stock Set to Flourishand 2 Facing Challenges